168 related articles for article (PubMed ID: 4613373)
1. Circulating antibodies in human connective tissue malignancy.
Moore M; Hughes LA
Br J Cancer Suppl; 1973 Aug; 1():175-84. PubMed ID: 4613373
[TBL] [Abstract][Full Text] [Related]
2. Further definition by cytotoxicity tests of cell surface antigens of human sarcomas in culture.
Bloom ET
Cancer Res; 1972 May; 32(5):960-7. PubMed ID: 4502173
[No Abstract] [Full Text] [Related]
3. Immunofluorescence tests on sera of patients with osteogenic sarcoma.
Priori ES; Wilbur JR; Dmochowski L
J Natl Cancer Inst; 1971 Jun; 46(6):1299-308. PubMed ID: 4932429
[No Abstract] [Full Text] [Related]
4. Cellular immunity to a common human sarcoma antigen and its specific inhibition by sera from patients with growing sarcomas.
Cohen AM; Ketcham AS; Morton DL
Surgery; 1972 Oct; 72(4):560-7. PubMed ID: 4506654
[No Abstract] [Full Text] [Related]
5. In vitro studies of cell mediated immunity to human sarcomas.
Rella W; Kotz R; Vetterlein M
Osterr Z Onkol; 1974; (3-4):89-96. PubMed ID: 4143396
[No Abstract] [Full Text] [Related]
6. Immunologic and virus studies with human sarcomas.
Morton DL; Malmgren RA; Hall WT; Schidlovsky G
Surgery; 1969 Jul; 66(1):152-61. PubMed ID: 4306938
[No Abstract] [Full Text] [Related]
7. Demonstration of common sarcoma-associated antigen(s) in an established human neurogenic sarcoma cell line.
Drewinko B; Montgomery CT; Trujillo JM
Cancer Res; 1973 Mar; 33(3):601-5. PubMed ID: 4347719
[No Abstract] [Full Text] [Related]
8. [Study of cellular immunity indices in patients with malignant tumors].
Govallo VI; Grigor'eva MP; Kosmiadi GA
Vopr Onkol; 1973; 19(11):18-21. PubMed ID: 4522541
[No Abstract] [Full Text] [Related]
9. Sarcoma-specific antigens: detection by complement fixation with serum from sarcoma patients.
Eilber FR; Morton DL
J Natl Cancer Inst; 1970 Mar; 44(3):651-6. PubMed ID: 11515434
[No Abstract] [Full Text] [Related]
10. Cell mediated immunity in human osteogenic sarcoma.
Agashe SS; Nair PN; Rao RS; Gangal SG
Indian J Cancer; 1975 Mar; 12(1):61-6. PubMed ID: 1058832
[No Abstract] [Full Text] [Related]
11. A panel of monoclonal antibodies which discriminate neuroblastoma from Ewing's sarcoma, rhabdomyosarcoma, neuroepithelioma, and hematopoietic malignancies.
Donner L; Triche TJ; Israel MA; Seeger RC; Reynolds CP
Prog Clin Biol Res; 1985; 175():347-66. PubMed ID: 3991736
[No Abstract] [Full Text] [Related]
12. Disappearance after chemotherapy of blocking serum factors as measured in vitro with lymphocytes cytotoxic to tumor cells.
Sinkovics JG; Cabiness JR; Shullenberger CC
Cancer; 1972 Dec; 30(6):1428-37. PubMed ID: 4509102
[No Abstract] [Full Text] [Related]
13. Immune factors in human cancer: malignant melanomas, skeletal and soft tissue sarcomas.
Morton DL; Eilber FR; Malmgren RA
Prog Exp Tumor Res; 1971; 14():25-42. PubMed ID: 5002728
[No Abstract] [Full Text] [Related]
14. [Clinico-immunological studies of 32 cases of bone tumors].
Franchi F; Russo V; Luzi G; Santori FS; De Chiara N; Aiuti F
Minerva Med; 1980 Jun; 71(25):1815-22. PubMed ID: 6968049
[TBL] [Abstract][Full Text] [Related]
15. [Humoral immunity in human sarcomas].
Sergeev SI; Bergol'ts VM; Kovalev BN; Timofeevskaia EA
Vopr Onkol; 1976; 22(8):17-21. PubMed ID: 1069401
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of host immunity in human neoplasia. 3. Discussion.
Br J Cancer Suppl; 1973 Aug; 1():185-6. PubMed ID: 4613374
[No Abstract] [Full Text] [Related]
17. Concentration of soluble CD44 standard and soluble CD44 variant V5 in the serum of patients with malignant bone tumors.
Holzer G; Kittl E; Pfandelsteiner T; Trieb K; Kotz R
Med Pediatr Oncol; 2003 Jan; 40(1):64-5. PubMed ID: 12426692
[No Abstract] [Full Text] [Related]
18. [Primary malignant tumors of the spinal column].
De Rubertis R
Arch Putti Chir Organi Mov; 1967; 22():186-208. PubMed ID: 4871170
[No Abstract] [Full Text] [Related]
19. [Characteristics of the immunohematologic status of patients with malignant bone neoplasms].
Zhukovskiĭ IIa; Bizer VA
Ter Arkh; 1978; 50(7):95-7. PubMed ID: 362593
[No Abstract] [Full Text] [Related]
20. Failure to detect circulating IgG or IgM antibodies to basal cell carcinoma by immunofluorescence.
Blewitt RW; Aparicio SR; Burrow HM; Rowell NR; Rowell RM
Acta Derm Venereol; 1978; 58(1):82-3. PubMed ID: 75642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
